Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
- TickerLUXHT
- Inception Date04/27/2021
- WeightingEqual
- # of holdings40
What's inside?
Holdings
All holdings as of August 6, 2026
| Guardant Health, Inc. (GH) | 12.06% | $21.15B | 44.33% | 65.39% | 17.39 |
| GRAIL, Inc. (GRAL) | 8.30% | $2.72B | 25.72% | -30.61% | 13.15 |
| Adaptive Biotechnologies Corp. (ADPT) | 7.42% | $3.77B | 21.53% | 70.15% | 11.37 |
| Twist Bioscience Corp. (TWST) | 4.51% | $6.84B | 23.24% | 52.76% | 14.70 |
| 10X Genomics, Inc. (TXG) | 4.15% | $5.79B | -12.65% | 74.48% | N/A |
| Natera, Inc. (NTRA) | 3.61% | $38.01B | 37.71% | 64.46% | N/A |
| iRhythm Holdings, Inc. (IRTC) | 3.57% | $4.21B | 20.08% | 72.80% | N/A |
| Progyny, Inc. (PGNY) | 3.35% | $2.37B | 5.30% | 25.48% | N/A |
| Hims & Hers Health, Inc. (HIMS) | 3.00% | $6.87B | 3.77% | 49.38% | 2.16 |
| CareDx, Inc. (CDNA) | 2.81% | $2.32B | 52.23% | 73.37% | 2.55 |
| Lifestance Health Group, Inc. (LFST) | 2.81% | $4.13B | 26.08% | 31.88% | 2.77 |
| Veracyte, Inc. (VCYT) | 2.54% | $3.71B | 15.49% | 71.93% | 7.78 |
| Illumina, Inc. (ILMN) | 2.52% | $29.25B | 9.84% | 66.49% | 6.31 |
| Oscar Health, Inc. (OSCR) | 2.47% | $8.00B | 70.40% | N/A | 0.65 |
| Clover Health Investments Corp. (CLOV) | 2.25% | $2.45B | 54.47% | N/A | N/A |
| DexCom, Inc. (DXCM) | 2.22% | $31.33B | 13.08% | 63.44% | 5.18 |
| NeoGenomics, Inc. (NEO) | 2.14% | $2.00B | 11.21% | 44.06% | 2.89 |
| Globus Medical, Inc. (GMED) | 2.06% | $11.00B | 5.94% | 65.92% | N/A |
| Veeva Systems, Inc. (VEEV) | 1.98% | $35.38B | 16.32% | 74.98% | 5.63 |
| Castle Biosciences, Inc. (CSTL) | 1.94% | $930.84M | 20.14% | 74.29% | 1.39 |
| Schrödinger, Inc. (SDGR) | 1.92% | $1.33B | 7.54% | 55.07% | N/A |
| IQVIA Holdings, Inc. (IQV) | 1.91% | $38.26B | 8.84% | 26.20% | 2.74 |
| ResMed, Inc. (RMD) | 1.78% | $32.38B | 9.85% | 60.25% | 4.92 |
| Fulgent Genetics, Inc. (FLGT) | 1.66% | $510.41M | 4.38% | 27.02% | 0.99 |
| Waystar Holding Corp. (WAY) | 1.61% | $4.48B | 18.11% | 56.47% | 4.35 |
| Tempus AI, Inc. (TEM) | 1.61% | $8.32B | 21.56% | 63.54% | 7.82 |
| Cytek Biosciences, Inc. (CTKB) | 1.52% | $540.73M | 5.57% | 58.87% | 1.68 |
| Intuitive Surgical, Inc. (ISRG) | 1.42% | $132.02B | 18.54% | 67.76% | 12.41 |
| Teladoc Health, Inc. (TDOC) | 1.41% | $1.21B | -3.95% | 53.58% | 0.72 |
| Align Technology, Inc. (ALGN) | 1.32% | $12.01B | 4.32% | 71.71% | 2.68 |
| Pacific Biosciences of California, Inc. (PACB) | 1.27% | $361.85M | -1.91% | 30.26% | 6.22 |
| GoodRx Holdings, Inc. (GDRX) | 1.15% | $1.27B | -1.31% | 78.42% | 1.59 |
| Insulet Corp. (PODD) | 1.13% | $9.66B | 23.51% | 72.56% | 3.60 |
| Doximity, Inc. (DOCS) | 0.93% | $3.71B | 7.34% | 82.13% | N/A |
| Tandem Diabetes Care, Inc. (TNDM) | 0.91% | $1.29B | 5.59% | 56.80% | N/A |
| Health Catalyst, Inc. (HCAT) | 0.79% | $170.70M | -12.68% | 34.67% | N/A |
| Inspire Medical Systems, Inc. (INSP) | 0.65% | $1.70B | -7.60% | 85.48% | 1.11 |
| PROCEPT BioRobotics Corp. (PRCT) | 0.59% | $1.15B | 19.34% | 66.01% | 3.37 |
| Definitive Healthcare Corp. (DH) | 0.38% | $98.50M | -5.51% | 59.58% | 0.69 |
| Myriad Genetics, Inc. (MYGN) | 0.32% | $304.17M | -10.51% | 62.51% | 0.79 |